Results 281 to 290 of about 50,635 (295)

Integrated molecular characterization of IDH‐mutant glioblastomas

Neuropathology and Applied Neurobiology, 2019
Andrey Korshunov, Lukas Chavez, Thomas Hielscher   +2 more
exaly  

Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis

Journal of Neuro-Oncology, 2013
Hairui Sun, Changxiang Yan, Yan Changxiang   +2 more
exaly  

Heterogeneous response of IDH-mutant and IDH-WT glioma to NAMPT inhibition

2020
Masum Rahman, Hirte, Renee, Olson, Ian E, Mansour, Moustafa A, Jibo Zhang, Ikram, Samar, Saber, Rehan, Rujapope Sutiwisesak, Muñoz-Casabella, Amanda, Carlstrom, Lucas P, Warrington, Arthur, Karishma Rajani, Sarkaria, Jann, Burns, Terry C   +13 more
openaire   +1 more source

Predicting IDH mutation status in grade II gliomas using amide proton transfer‐weighted (APTw) MRI

Magnetic Resonance in Medicine, 2017
Shanshan Jiang, Tianyu Zou, Hye-Young Heo   +2 more
exaly  

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

Cell Reports, 2017
Ewan A Gibb, Jason Roszik, Apurva M Hegde   +2 more
exaly  

MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis

American Journal of Roentgenology, 2018
Javier E Villanueva-Meyer, Matthew D Wood, Byung Se Choi   +2 more
exaly  

IDH mutated gliomas

Journal of the Neurological Sciences, 2021
openaire   +1 more source

Characterization of a mutation in the IDH-II subunit of the NAD+-dependent isocitrate dehydrogenase from Arabidopsis thaliana

Plant Science, 2004
David J Oliver
exaly  

Glioblastoma, IDH-wildtype

2022
openaire   +1 more source

[Ⅳ. IDH Inhibitor].

Gan to kagaku ryoho. Cancer & chemotherapy, 2022
Fumiya, Wada, Tadakazu, Kondo
openaire   +1 more source